Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target Vulnerability
ACS Infectious Diseases · 2025
DOI: 10.1021/acsinfecdis.4c01017 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Mingqian Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Study of Drug Action, and Department of Chemistry, Stony Brook University, Stony Brook, New York 11794-3400, United States. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents, Leucine-tRNA Ligase, Enzyme Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
The postantibiotic effect (PAE) is the persistent suppression of microbial growth following the removal of antimicrobial therapy. In general, antibiotics that generate a PAE are dosed less frequently, and thus, the PAE has important implications for dosing regimens. PAEs can arise through several mechanisms, including the extended occupancy of the drug target following drug elimination, and the correlation between drug-target residence time and PAE provides insight into target vulnerability. To assess the vulnerability of Escherichia coli leucyl-tRNA synthetase (ecLeuRS), which is an essential enzyme in protein synthesis, the time-dependent inhibition of the enzyme was studied by the benzoxaborole class of compounds that inhibit LeuRS by forming a stable LeuRS-tRNALeu-benzoxaborole adduct. Preincubation of epetraborole with ecLeuRS resulted in a decrease in the IC50 value for enzyme inhibition from 38 to 3 nM, consistent with the slow formation of the final enzyme-inhibitor complex, and similar shifts in IC50 were observed for three other benzoxaboroles. The benzoxaboroles generated short PAEs (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Advanced Study of Drug Action, and Department of Chemistry, Stony Brook University, Stony Brook, New York 11794-3400, United States.
- Department of Pathology, Stony Brook University, Stony Brook, New York 11794-8691, United States.
- Department of Oral Biology and Pathology, Stony Brook University, Stony Brook, New York 11794-8702, United States.
- AN2 Therapeutics, Menlo Park, California 94027, United States.
ORCID-Profile: Amanda R Strohm, Peter J Tonge
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Wang, M., He, Y., Cohen, S. A., Strohm, A. R., Haley, J. D., Walker, S. G., Alley, M. R. K., & Tonge, P. J. (2025). Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target Vulnerability. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c01017
Vancouver
Wang M, He Y, Cohen SA, Strohm AR, Haley JD, Walker SG, et al. Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target Vulnerability. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.4c01017
BibTeX
@article{Wang2025,
author = {Wang, Mingqian and He, YongLe and Cohen, Siobhan A and Strohm, Amanda R and Haley, John D and Walker, Stephen G and Alley, M R K and Tonge, Peter J},
title = {Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target Vulnerability},
journal = {ACS Infectious Diseases},
year = {2025},
doi = {10.1021/acsinfecdis.4c01017}
}
EUVIMED